ADMA, ADMA Biologics Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for ADMA

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask ADMA by Subscribing to iPick.ai Premium!



Stock Chart




Latest YouTube Video:

Please Login/Register (click on the top-right button) to see the latest video on ADMA, ADMA Biologics Inc.

CEO:Mr. Adam S. Grossman

Headquarter: 465 State Route 17, Ramsey, NJ, United States, 07446

Industry: Biotechnology,   Employees: 685

Business Summary

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.